洁特生物：2024年净利润7381.42万元 同比增长112.18%

Core Viewpoint - Jiet Bio (688026) reported a revenue of 557 million yuan for 2024, representing a year-on-year growth of 20.28%, and a net profit of 73.81 million yuan, with a significant increase of 112.18% [1] Group 1: Financial Performance - The company's revenue for 2024 reached 557 million yuan, marking a 20.28% increase compared to the previous year [1] - Net profit for the same period was 73.81 million yuan, reflecting a substantial growth of 112.18% year-on-year [1] - Basic earnings per share stood at 0.53 yuan [1] Group 2: Market and Industry Trends - The domestic substitution policy has reduced the dependency on imported life science research tools, benefiting the company as a national-level specialized and innovative "little giant" enterprise [1] - Emerging technologies such as cell therapy and gene editing are driving the demand for high-end consumables [1] - The expansion of innovative drug companies and the increase in high-value orders from industrial clients are contributing to the company's growth [1]